Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
Clostridium difficile (C. difficile) infection (CDI) is the main cause of nosocomial antibiotic-associated colitis and increased incidence of community-associated diarrhea in industrialized countries. At present, the primary treatment of CDI is antibiotic administration, which is effective but often...
Main Authors: | Hongyu Qiu, Robyn Cassan, Darrell Johnstone, Xiaobing Han, Antony George Joyee, Monica McQuoid, Andrea Masi, John Merluza, Bryce Hrehorak, Ross Reid, Kieron Kennedy, Bonnie Tighe, Carla Rak, Melanie Leonhardt, Brian Dupas, Laura Saward, Jody D Berry, Cory L Nykiforuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4919053?pdf=render |
Similar Items
-
Exploring the inhibitory potential of the antiarrhythmic drug amiodarone against Clostridioides difficile toxins TcdA and TcdB
by: Judith Schumacher, et al.
Published: (2023-12-01) -
Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
by: Hamideh Raeisi, et al.
Published: (2023-10-01) -
A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from <i>Clostridioides difficile</i>
by: Diane Sapa, et al.
Published: (2024-01-01) -
Human α-Defensin-6 Neutralizes <i>Clostridioides difficile</i> Toxins TcdA and TcdB by Direct Binding
by: Lara Barthold, et al.
Published: (2022-04-01) -
Neutralising Effects of Different Antibodies on <i>Clostridioides difficile</i> Toxins TcdA and TcdB in a Translational Approach
by: Georg Csukovich, et al.
Published: (2023-02-01)